N. Mengeş Et Al. , "İmidazopyridines and Their Biological Evaluation as Potent Anticancer Agents: A promising Candidate for Glioblastoma," 12th International Symposium on Pharmaceutical Sciences , Ankara, Turkey, pp.47-48, 2018
Mengeş, N. Et Al. 2018. İmidazopyridines and Their Biological Evaluation as Potent Anticancer Agents: A promising Candidate for Glioblastoma. 12th International Symposium on Pharmaceutical Sciences , (Ankara, Turkey), 47-48.
Mengeş, N., Kuzu, B., GÜÇLÜ, D., Taşpınar, F., Canpınar, H., Tozlu, İ., ... Taşpınar, M.(2018). İmidazopyridines and Their Biological Evaluation as Potent Anticancer Agents: A promising Candidate for Glioblastoma . 12th International Symposium on Pharmaceutical Sciences (pp.47-48). Ankara, Turkey
Mengeş, Nurettin Et Al. "İmidazopyridines and Their Biological Evaluation as Potent Anticancer Agents: A promising Candidate for Glioblastoma," 12th International Symposium on Pharmaceutical Sciences, Ankara, Turkey, 2018
Mengeş, Nurettin Et Al. "İmidazopyridines and Their Biological Evaluation as Potent Anticancer Agents: A promising Candidate for Glioblastoma." 12th International Symposium on Pharmaceutical Sciences , Ankara, Turkey, pp.47-48, 2018
Mengeş, N. Et Al. (2018) . "İmidazopyridines and Their Biological Evaluation as Potent Anticancer Agents: A promising Candidate for Glioblastoma." 12th International Symposium on Pharmaceutical Sciences , Ankara, Turkey, pp.47-48.
@conferencepaper{conferencepaper, author={Nurettin Mengeş Et Al. }, title={İmidazopyridines and Their Biological Evaluation as Potent Anticancer Agents: A promising Candidate for Glioblastoma}, congress name={12th International Symposium on Pharmaceutical Sciences}, city={Ankara}, country={Turkey}, year={2018}, pages={47-48} }